Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models
Qingshan Wang, Li Qian, Shih Heng Chen, Chun Hsien Chu, Belinda Wilson, Esteban Oyarzabal, Syed Ali, Bonnie Robinson, Deepa Rao, Jau Shyong Hong
Dive into the research topics of 'Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models'. Together they form a unique fingerprint.